This article provides an overview of work and mission of Levels as a company.
In this Article:
Levels helps you see how food affects your health. By leveraging biosensors like continuous glucose monitors (CGM), Levels provides real-time feedback on how diet and lifestyle choices impact your metabolic health. Our Members are using personalized data to discover their optimal diet, control their weight, and reduce long-term health risk.
Levels has raised a total of $50M, including a Series A in April 2022. Investors include Andreessen Horowitz, Marc Randolph (co-founder, Netflix), Esther Dyson, Dick Costolo (former CEO, Twitter), Michael Arrington (Founder, TechCrunch), Matt Dellavedova (NBA, Cleveland Cavaliers), Fidji Simo (CEO, Instacart) and others.
The Levels Advisory Board includes key thought leaders, clinicians and researchers in metabolic health, including David Sinclair, PhD, Dr. Robert Lustig, Dr. Sara Gottfried, Ben Bikman, PhD, Dom D’Agostino, PhD, Dr. Mark Hyman, Dr. Molly Maloof, Dr. David Perlmutter and Dr. Gerald Shulman.
What we build at Levels has a singular focus: To solve the metabolic health crisis.
At the time of this writing, 70% of the US population is overweight or obese, U.S. life-expectancy has dropped for 3 consecutive years, 3 of the 10 leading causes of death are diabetes associated, and many researchers have recently begun referring to a 4th leading cause of death*—Alzheimer's Disease—*as “Type 3 Diabetes”. These illnesses are quietly destructive: prediabetes is nearly asymptomatic and once diabetes arrives it kills slowly, first ushering in blindness, amputations, heart disease, and strokes.
The scale and nature of the metabolic epidemic requires a new strategy: making health information accessible to the individual to whom it belongs, in real time, for prevention rather than reaction. This is the mission of Levels.
Levels gives people the tools they need to improve their health. Our vision is to provide integrated technology that tracks every meaningful metric related to metabolic health and longevity in near-real-time and to provide actionable feedback on how our customers can improve their lives. Levels is not a wearable device company. We are an engineering company enabling individualized healthcare. The metrics we provide access to are deep, insightful biomarkers, clinically proven to define health and risk of disease.
To provide the access, technology, and expertise necessary for anyone to understand the biological status of their own body. Democratized access to health data is foundational for improving human flourishing through increased awareness and prevention of disease.
To read more about Levels vision to build the most affordable product to reverse metabolic dysfunction, check out The Secret Levels Master Plan, written by Levels CEO, Sam Corcos.